CAR-T（CAR-T）细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
Emapalumab 和 eltrombopag 用于多发性骨髓瘤 CAR-T 细胞治疗后迁延性免疫效应细胞相关噬血细胞综合征的挽救治疗
英文原题：Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myeloma.
查看英文原题
Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myeloma.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
中文摘要
暂无。
展开英文摘要原文
Not available.
论文信息
- 作者
- Mouhieddine TH、Santos JVD、Sehgal H、Salib C、Hussein S、Duffield A、Richard S、Aleman A
- 单位
- Tisch Cancer Center, Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Jerome Lipper Multiple Myeloma Center, Division of Plasma Cell Neoplasias, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Tarek_Mouhieddine@DFCI.harvard.edu.United States
- 期刊
- Haematologica2026 Jul 2
- 原文标识
- PubMed 42389839 · DOI 10.3324/haematol.2026.300894